✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹562 Cr.
P/E
79.06

Key Ratios

Market cap
Market cap
562 Cr
PE
PE
79.06
Prom Holding
Prom Holding
43.16 %
ROE (%)
ROE (%)
4.59
ROCE (%)
ROCE (%)
9.04
Div Yield (%)
Div Yield (%)
0.24
Sales
Sales
162 Cr
OPM (%)
OPM (%)
8.53 %
Debt to Equity
Debt to Equity
0.16
About
Medicamen Biotech Limited is a pharmaceutical company engaged in manufacturing and marketing p… Read more
Low
375
52W Range
High
630
  • Medicamen Biotech
  • Prevest Denpro
  • Zim Laboratories
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

5 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison
Corporate Actions
Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less
FAQs on Medicamen Biotech Ltd. Business

Medicamen Biotech Limited is a pharmaceutical company that manufactures and markets a variety of pharmaceutical formulations globally. Its product range includes tablets, capsules, liquid syrups, and dry syrups.

Medicamen Biotech major competitors are Prevest Denpro, Jenburkt Pharma, Zim Laboratories, Venus Remedies, Albert David, Ind-Swift Lab., Brooks Laboratories.
Market Cap of Medicamen Biotech is ₹565 Crs.
While the median market cap of its peers are ₹559 Crs.

Medicamen Biotech seems to be less financially stable compared to its competitors.
Altman Z score of Medicamen Biotech is 5.94 and is ranked 4 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation Sep Mar Sep Dec Sep Mar Jun Sep Jun Jun Sep
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material